rs772296795
Variant summary
Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PM2PP3_ModeratePP5_Very_Strong
The NM_032861.4(SERAC1):c.1167_1170delTCAG(p.Gln390ProfsTer29) variant causes a frameshift, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000087 in 1,608,906 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032861.4 frameshift, splice_region
Scores
Clinical Significance
Conservation
Publications
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032861.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SERAC1 | NM_032861.4 | MANE Select | c.1167_1170delTCAG | p.Gln390ProfsTer29 | frameshift splice_region | Exon 12 of 17 | NP_116250.3 | ||
| SERAC1 | NR_073096.2 | n.1177_1180delTCAG | splice_region non_coding_transcript_exon | Exon 11 of 13 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SERAC1 | ENST00000647468.2 | MANE Select | c.1167_1170delTCAG | p.Gln390ProfsTer29 | frameshift splice_region | Exon 12 of 17 | ENSP00000496731.1 | ||
| SERAC1 | ENST00000606965.5 | TSL:1 | n.1053_1056delTCAG | splice_region non_coding_transcript_exon | Exon 11 of 13 | ENSP00000475808.1 | |||
| SERAC1 | ENST00000607742.5 | TSL:1 | n.*1001_*1004delTCAG | splice_region non_coding_transcript_exon | Exon 11 of 15 | ENSP00000475523.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000415 AC: 1AN: 240762 AF XY: 0.00000769 show subpopulations
GnomAD4 exome AF: 0.00000892 AC: 13AN: 1456720Hom.: 0 AF XY: 0.00000828 AC XY: 6AN XY: 724232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Pathogenic:3
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with SERAC1-related disorder (ClinVar ID: VCV000035558 / PMID: 22683713). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at